Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy
Early post-treatment <sup>18</sup>F-FDG PET/CT can provide valuable prognostic information for DLBCL patients receiving CAR-T. The most significant predictors of outcomes would be the baseline extent of the disease, one-month post-treatment avidity, and changes in the metabolic burden from baseline.
Authors
- Andrés Kohan (ORCID: https://orcid.org/0000-0003-3592-3000)
- Patrick Veit‐Haibach (ORCID: https://orcid.org/0000-0002-8607-2667)
- David Hodgson (ORCID: https://orcid.org/0000-0003-4687-4582)
- Roshini Kulanthaivelu (ORCID: https://orcid.org/0000-0002-2279-8346)
- Robert Kridel (ORCID: https://orcid.org/0000-0003-0287-7124)
- Ur Metser (ORCID: https://orcid.org/0000-0003-3726-8994)
- Sita Bhella (ORCID: https://orcid.org/0009-0005-9553-4340)
- Claudia Ortega (ORCID: https://orcid.org/0000-0003-3357-1849)
- Seyed Ali Mirshahvalad (ORCID: https://orcid.org/0000-0003-2271-9764)
- Christine Chen (ORCID: https://orcid.org/0000-0003-4377-8245)
- K. Chin
Institutions
- University Health Network (CA)
- Women's College Hospital (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2025-06-08
- DOI
- https://doi.org/10.1186/s40644-025-00888-8
- Citations
- 4
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 4.18